Gufic Biosciences surges on getting nod for scheme of amalgamation

10 Nov 2017 Evaluate

Gufic Biosciences is currently trading at Rs. 88.90, up by 1.30 points or 1.48% from its previous closing of Rs. 87.60 on the BSE.

The scrip opened at Rs. 87.55 and has touched a high and low of Rs. 90.50 and Rs. 86.80 respectively. So far 20916 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 99.60 on 24-Oct-2017 and a 52 week low of Rs. 40.90 on 17-Nov-2016.

Last one week high and low of the scrip stood at Rs. 93.50 and Rs. 85.55 respectively. The current market cap of the company is Rs. 691.51 crore.

The promoters holding in the company stood at 69.98%, while institutions and non-institutions held 8.88% and 21.14% respectively.

Gufic Biosciences has received an approval for the Scheme of Amalgamation of Gufic Lifesciences with itself. The Board of Directors of the Company at its meeting held on November 09, 2017 has approved the same.

Gufic Biosciences is engaged in diversified business viz. Pharma, Healthcare, Bio- Technology, Seeds, Herbal etc.

Gufic Biosciences Share Price

403.15 -4.70 (-1.15%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.80
Dr. Reddys Lab 1213.90
Cipla 1486.30
Lupin 2069.95
Zydus Lifesciences 948.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.